Mangoceuticals, INC. (MGRX) — 10-K Filings
All 10-K filings from Mangoceuticals, INC.. Browse 3 Annual Report reports with AI-powered summaries and risk analysis.
10-K Filings (3)
-
MGRX Under Scrutiny After Reverse Split, Trading Irregularities
— Apr 1, 2026 Risk: high
MANGOCEUTICALS, INC. (MGRX) focuses on men's wellness products and telemedicine services, including treatments for erectile dysfunction (Mango ED), hair loss (G -
Mangoceuticals Files 2024 Annual Report
— Mar 20, 2025 Risk: medium
Mangoceuticals, Inc. filed its 2024 10-K on March 20, 2025, reporting on its fiscal year ending December 31, 2024. The company, incorporated in Texas, operates -
Mangoceuticals, Inc. Files 2023 Annual Report on Form 10-K
— Apr 1, 2024 Risk: low
MANGOCEUTICALS, INC. (MGRX) filed a Annual Report (10-K) with the SEC on April 1, 2024. Mangoceuticals, Inc. filed its 2023 annual report on Form 10-K on April
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX